Back to results

Massachusetts Institute of Technology

Mechanistic investigation of an anticancer agent that damages DNA and interacts with the androgen receptor

Abstract

dc:description.abstract

The 11[beta] molecule comprises a ligand for the androgen receptor (AR), which is crucial to progression and survival of many prostate cancers, tethered to a DNA-damaging aniline mustard. The compound was designed to exhibit selective toxicity toward prostate cancer cells by forming sites of 11[beta]P -DNA damage to which AR binds, physically blocking access of repair enzymes while becoming unavailable to activate transcription of pro-survival genes. Previous studies have demonstrated the ability of 11[beta] 3 to damage DNA, retain affinity for AR when covalently adducted to DNA, and prevent selectively the growth of prostate xenograft tumors implanted in mice. Here we demonstrate that 11[beta] promotes phosphorylation and nuclear localization of AR, resulting in receptor association with androgen response elements. However, 11[beta] 3 only weakly drives AR transcriptional activity, and instead moderately antagonizes AR-mediated transcription elicited by natural androgens. Furthermore, 11[beta]0 dramatically decreases steady-state levels of AR protein. Collectively, these activities limit the expression of androgen-regulated genes and could control toxicity in AR-expressing prostate cancers. Despite possessing an ability to modulate AR transcriptional activity, 11[beta]0 is not selectively toxic toward the AR-positive member of an otherwise isogenic pair of prostate cancer cell lines derived from PC3 cells, which do not depend on AR-mediated gene expression for growth or survival. Therefore, the extraneous presence of AR does not increase 11[beta]13 toxicity.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Dept. of Chemistry.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2009

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Proffitt, Kyle David
Advisor dc:contributor.advisor
  • John Martin Essigmann.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/49747
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/49747

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
related terms
citation

Proffitt, Kyle David. Mechanistic investigation of an anticancer agent that damages DNA and interacts with the androgen receptor. Massachusetts Institute of Technology, 2009. http://hdl.handle.net/1721.1/49747